DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY
Editorial use only.
Pazopanib cancer drug. Bottle containing 400mg tablets of the anti-cancer drug pazopanib, marketed under the name Votrient. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis, the production of new blood vessels. It is used to treat renal cell (kidney) carcinoma and soft tissue sarcoma.
Model release not required. Property release not required.